|
1
|
Reed LJ: A trail of research from lipoic
acid to alpha-keto acid dehydrogenase complexes. J Biol Chem.
276:38329–38336. 2001.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Parente E, Colannino G, Picconi O and
Monastra G: Safety of oral alpha-lipoic acid treatment in pregnant
women: A retrospective observational study. Eur Rev Med Pharmacol
Sci. 18:4219–4227. 2017.PubMed/NCBI
|
|
3
|
Smith AR, Shenv SV, Widlansky M, Suh JH
and Hagen TM: Lipoic acid as a potential therapy for chronic
diseases associated with oxidative stress. Curr Med Chem.
11:1135–1146. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mayr JA, Feichtinger RG, Tort F, Ribes A
and Sperl W: Lipoic acid biosynthesis defects. J Inherit Metab Dis.
37:553–563. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Monastra G, De Gazia S, Cilaker Micili S,
Goker A and Unfer V: Immunomodulatory activities of alpha lipoic
acid with a special focus on its efficacy in preventing
miscarriage. Expert Opin Drug Deliv. 13:1695–1708. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gorąca A, Huk-Kolega H, Piechota A,
Keniewska P, Ciejka E and Skibska B: Lipoic acid-biological
activity and therapeutic potential. Pharmacol Rep. 63:849–858.
2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Biewenga GP, Haenen GR and Bast A: The
pharmacology of the antioxidant lipoic acid. Gen Pharmacol.
29:315–331. 1997.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hermann R, Niebch G, Borbe HO,
Fieger-Büschges H, Ruus P, Nowak H, Riethmüller-Winzen H, Peukert M
and Blume H: Enantioselective pharmacokinetics and bioavailability
of different racemic α-lipoic acid formulations in healthy
volunteers. Eur J Pharm Sci. 4:167–174. 1996.
|
|
9
|
Kliman HJ and Milano KM: The majority of
miscarriages are caused by genetic abnormalities. Fertil Steril.
100(S306)2013.
|
|
10
|
Kwak-Kim J, Yang KM and Gilman-Sachs A:
Recurrent pregnancy loss: A disease of inflammation and
coagulation. J Obstet Gynaecol Res. 35:609–622. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Christiansen OB, Nielsen HS and Kolte AM:
Inflammation and miscarriage. Semin Fetal Neonatal Med. 11:302–308.
2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yassaee F, Shekarriz-Foumani R, Afsari S
and Fallahian M: The effect of progesterone suppositories on
threatened abortion: A randomized clinical trial. J Reprod
Infertil. 15:147–151. 2014.PubMed/NCBI
|
|
13
|
Wada H, Shintani D and Ohlrogge J: Why do
mitochondria synthesize fatty acids? Evidence for involvement in
lipoic acid production. Proc Natl Acad Sci USA. 94:1591–1596.
1997.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Teichert J and Preiss R: HPLC-methods for
determination of lipoic acid and its reduced form in human plasma.
Int J Clin Pharmacol Ther Toxicol. 30:511–512. 1992.PubMed/NCBI
|
|
15
|
Duhig K, Chappell LC and Shennan AH:
Oxidative stress in pregnancy and reproduction. Obstet Med.
9:113–116. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Toy H, Camuzcuoglu H, Camuzcuoglu A, Celik
H and Aksoy N: Decreased serum prolidase activity and increased
oxidative stress in early pregnancy loss. Gynecol Obstet Invest.
69:122–127. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Safronova VG, Matveeva NK, Avkhacheva NV,
Sidel'nikova VM, Van'ko LV and Sukhikh GT: Changes in regulation of
oxidase activity of peripheral blood granulocytes in women with
habitual abortions. Bull Exp Biol Med. 136:257–260. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Spector A, Huang RR, Yan GZ and Wang RR:
Thioredoxin fragment 31-36 is reduced by dihydrolipoamide and
reduces oxidized protein. Biochem Biophys Res Commun. 150:156–162.
1988.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Salehi B, Berkay Yılmaz Y, Antika G,
Boyunegmez Tumer T, Fawzi Mahomoodally M, Lobine D, Akram M, Riaz
M, Capanoglu E, Sharopov F, et al: Insights on the Use of α-lipoic
acid for therapeutic purposes. Biomolecules. 9:9–356.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shay KP, Moreau RF, Smith EJ and Hagen TM:
Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and
therapeutic potential. Biochim Biophys Acta. 1790:1149–1160.
2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Luckheeram RV, Zhou R, Verma AD and Xia B:
CD4+ T cells: Differentiation and functions. Clin Dev
Immunol. 2012(925135)2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Torchinsky A, Shepshelovich J, Orenstein
H, Zaslavsky Z, Savion S, Carp H, Fein A and Toder V: TNF-alpha
protects embryos exposed to developmental toxicants. Am J Reproduct
Immunol. 49:159–168. 2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang W, Sung N, Gilman-Sachs A and
Kwak-Kim J: T Helper (Th) cell profiles in pregnancy and recurrent
pregnancy losses: Th1/Th2/Th9/Th17/Th22/Tfh cells. Front Immunol.
11(2025)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bauer S, Pollheimer J, Hartmann J,
Husslein P, Aplin JD and Knöfler M: Tumor necrosis factor-alpha
inhibits trophoblast migration through elevation of plasminogen
activator inhibitor-1 in first-trimester villous explant cultures.
J Clin Endocrinol Metabol. 89:812–822. 2004.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Renaud SJ, Postovit LM,
Macdonald-Goodfellow SK, McDonald GT, Caldwell JD and Graham CH:
Activated macrophages inhibit human cytotrophoblast invasiveness in
vitro. Biol Reprod. 73:237–243. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Vitoratos N, Papadias C, Economou E,
Makrakis E, Panoulis C and Creatsas G: Elevated circulating
IL-1beta and TNF-alpha, and unaltered IL-6 in first-trimester
pregnancies complicated by threatened abortion with an adverse
outcome. Mediators Inflamm. 2006(30485)2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Saito S, Nakashima A, Shima T and Ito M:
Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J
Reprod Immunol. 63:601–610. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Prins JR, Gomez-Lopez N and Robertson SA:
Interleukin-6 in pregnancy and gestational disorders. J Reprod
Immunol. 95:1–14. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chatterjee P, Chiasson VL, Bounds KR and
Mitchell BM: Regulation of the anti-inflammatory cytokines
Interleukin-4 and Interleukin-10 during pregnancy. Front Immunol.
5(253)2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kaminski VD, Ellwanger JH, Matte MCC,
Savaris RF, Vianna P and Chies JAB: IL-17 blood levels increase in
healthy pregnancy but not in spontaneous abortion. Mol Biol Rep.
45:1565–1568. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lombardelli L, Logiodice F, Aguerre-Girr
M, Kullolli O, Haller H, Casart Y, Berrebi A, L'Faqihi-Olive FE,
Duplan V, Romagnani S, et al: Interleukin-17-producing decidual
CD4+ T cells are not deleterious for human pregnancy when they also
produce interleukin-4. Clin Mol Allergy. 14(1)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Nakashima A, Ito M, Shima T, Bac ND,
Hidaka T and Saito S: Accumulation of IL-17-positive cells in
decidua of inevitable abortion cases. Am J Reprod Immunol. 64:4–11.
2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wang WJ, Hao CF, Yi-Lin Yin GJ, Bao SH,
Qiu LH and Lin QD: Increased prevalence of T helper 17 (Th17) cells
in peripheral blood and decidua in unexplained recurrent
spontaneous abortion patients. J Reprod Immunol. 84:164–170.
2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu YS, Wu L, Tong XH, Wu LM, He GP, Zhou
GX, Luo LH and Luan HB: Study on the relationship between Th17
cells and unexplained recurrent spontaneous abortion. Am J Reprod
Immunol. 65:503–511. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Osorio F, Leibund Gut-Landmann S, Lochner
M, Lahl K, Sparwasser T, Eberl G and Reis e Sousa C: DC activated
via dectin-1 convert Treg into IL-17 producers. Eur J Immunol.
38:3274–3281. 2008.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu HP, Cao AT, Feng T, Li Q, Zhang W, Yao
S, Dann SM, Elson CO and Cong Y: TGF-β converts Th1 cells into Th17
cells through stimulation of Runx1 expression. Eur J Immunol.
45:1010–1018. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Attia M, Essa EA, Zaki RM and Elkordy AA:
An overview of the antioxidant effects of ascorbic acid and alpha
lipoic acid (in liposomal forms) as adjuvant in cancer treatment.
Antioxidants (Basel). 9(359)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Porcaro G, Brillo E, Giardina I and Di
Iorio R: Alpha Lipoic Acid (ALA) effects on subchorionic hematoma:
Preliminary clinical results. Eur Rev Med Pharmacol Sci.
19:3426–3432. 2015.PubMed/NCBI
|
|
39
|
Costantino M, Guaraldi C and Costantino D:
Resolution of subchorionic hematoma and symptoms of threatened
miscarriage using vaginal alpha lipoic acid or progesterone:
Clinical evidences. Eur Rev Med Pharmacol Sci. 20:1656–1663.
2016.PubMed/NCBI
|
|
40
|
Di Tucci C, Di Feliciantonio M, Vena F,
Capone C, Schiavi MC, Pietrangeli D, Muzii L and Benedetti Panici
P: Alpha lipoic acid in obstetrics and gynecology. Gynecol
Endocrinol. 34:729–733. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Pashaj A, Xia M and Moreau R: α-Lipoic
acid as a triglyceride-lowering nutraceutical. Can J Physiol
Pharmacol. 93:1029–1041. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Parente E, Colannino G and Ferrara P:
Efficacy of magnesium and alpha lipoic acid supplementation in
reducing premature uterine contractions. Open J Obstet Gynecol.
4:578–583. 2014.
|
|
43
|
Carson RJ: Detection and prevention of
premature labour. Neuro Endocrinol Lett. 25 (Suppl 1):S35–S41.
2004.PubMed/NCBI
|
|
44
|
Hubinont C and Debieve F: Prevention of
preterm labour: 2011 update on tocolysis. J Pregnancy.
2011(941057)2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Connon CJ, Nakamura T, Hopkinson A,
Quantock A, Yagi N, Doutch J and Meek KM: The biomechanics of
amnion rupture: An X-ray diffraction study. PLoS One.
2(e1147)2007.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Snegovskikh V, Park JS and Norwitz ER:
Endocrinology of parturition. Endocrin Metabol Clin North Am.
35:173–191. 2006.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Moore RM, Novak JB, Kumar D, Mansour JM,
Mercer BM and Moore JJ: Alpha-Lipoic Acid inhibits tumor necrosis
factor-induced remodeling and weakening of human fetal membranes.
Biol Reprod. 80:781–787. 2008.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Moore RM, Schatz F, Kumar D, Mercer BM,
Abdelrahim A, Rangaswamy N, Bartel C, Mansour JM, Lockwood CJ and
Moore JJ: Alpha-lipoic acid inhibits thrombin-induced fetal
membrane weakening in vitro. Placenta. 31:886–892. 2010.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Grandi G, Pignatti L, Ferrari F, Dante G,
Neri I and Facchinetti F: Vaginal alpha-lipoic acid shows an
anti-inflammatory effect on the cervix, preventing its shortening
after primary tocolysis. A pilot, randomized, placebo-controlled
study. J Matern Fetal Neonatal Med. 30:2243–2249. 2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Vitrano G, Mocera G, Guardino M,
Giallombardo V and Venezia R: Oral plus vaginal alpha-lipoic acid
in women at risk for preterm delivery. IJMDAT. 1(e104)2018.
|
|
51
|
Wei SQ, Fraser W and Luo ZC: Inflammatory
cytokines and spontaneous preterm birth in asymptomatic women: A
systematic review. Obstet Gynecol. 116:393–401. 2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK,
Park JY, Lee KU, Kim JG and Lee IK: Alpha-lipoic acid inhibits
matrix metalloproteinase-9 expression by inhibiting NF-kappaB
transcriptional activity. Exp Mol Med. 39:106–113. 2007.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Myatt L and Cui X: Oxidative stress in the
placenta. Histochem Cell Biol. 122:369–382. 2004.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Walsh SW and Wang Y: Secretion of lipid
peroxides by the human placenta. Am J Obstet Gynecol.
169:1462–1466. 1993.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Redman CW and Sargent IL: Placental
debris, oxidative stress and preeclampsia. Placenta. 21:597–602.
2000.PubMed/NCBI View Article : Google Scholar
|
|
56
|
McKinney ET, Shouri R, Hunt RS, Ahokas RA
and Sibai BM: Plasma, urinary, and salivary 8-epi-prostaglandin
f2alpha levels in normotensive and preeclamptic pregnancies. Am J
Obstet Gynecol. 183:874–877. 2000.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Aouache R, Biquard L, Vaiman D and
Miralles F: Oxidative stress in preeclampsia and placental
diseases. Int J Mol Sci. 19(1496)2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Buonocore G, Perrone S and Tataranno ML:
Oxygen toxicity: Chemistry and biology of reactive oxygen species.
Semin Fetal Neonatal Med. 15:186–190. 2010.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Poston L, Igosheva N, Mistry HD, Seed PT,
Shennan AH, Rana S, Karumanchi SA and Chappell LC: Role of
oxidative stress and antioxidant supplementation in pregnancy
disorders. Am J Clin Nutr. 94 (6 Suppl):1980S–1985S.
2011.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Lewen A, Matz P and Chan PH: Free radical
pathways in CNS injury. J Neurotrauma. 17:871–890. 2000.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Gug C, Rațiu A, Navolan D, Drăgan I, Groza
IM, Păpurică M, Vaida MA, Mozoș I and Jurcă MC: Incidence and
spectrum of chromosome abnormalities in miscarriage samples: A
retrospective study of 330 cases. Cytogenet Genome Res.
158:171–183. 2019.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Wolz P and Krieglstein J: Neuroprotective
effects of alpha-lipoic acid and its enantiomers demonstrated in
rodent models of focal cerebral ischemia. Neuropharmacology.
35:369–375. 1996.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Mei XH and Yang YW: Neuroprotective
effects of α-lipoic acid against hypoxic-ischemic brain injury in
neonatal rats. Trop J Pharm Res. 16:1051–1058. 2017.
|
|
64
|
Miller SL, Wallace EM and Walker DW:
Antioxidant therapies: A potential role in perinatal medicine.
Neuroendocrinology. 96:13–23. 2012.PubMed/NCBI View Article : Google Scholar
|
